Expert Management of Treatment-Related Symptoms Associated With BCL-2 Inhibitors in Hematologic Malignancies

Get expert guidance on managing adverse events associated with BCL-2 inhibitors in hematologic malignancies using an interactive treatment decision tool to provide expert recommendations on managing key toxicities, then download a patient resource and read an expert authored CME/CNE/CPE-certified text module with downloadable slides.

Share

Program Content

Activities

BCL2  Inhibitor Therapy
Understanding BCL-2 Inhibitor Treatment and Management of Potential Side Effects
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 20, 2024

Expires: May 19, 2025

Activities

BCL2AETooL
Interactive Tool for Managing Adverse Events Associated With BCL-2 Inhibitors in Hematologic Malignancies
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2024

Expires: August 22, 2025

Activities

BCL-2i AE Management
Expert Management of Treatment-Related Adverse Events From BCL-2 Inhibitors
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2024

Expires: March 31, 2025

Activities

BCL-2 Inhibitor AE Management
Expert Management of Treatment-Related Adverse Events From BCL-2 Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2024

Expires: October 01, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AbbVie Inc.

AbbVie Inc.